De Luis Román Daniel Antonio, Primo David, Izaola Olatz, Aller Rocío
Institute of Endocrinology and Nutrition. Medicine Schooll. Valladolid University..
Nutr Hosp. 2017 Mar 30;34(2):383-388. doi: 10.20960/nh.384.
Trp64Arg variant in beta 3 adrenoreceptor has been reported to be associated with increased body weight and insulin resistance. These risk factors are the ones that make up the so-called metabolic syndrome. The aim of our study was to investigate the relationship between metabolic syndrome and Trp64Arg polymorphism in the beta3 adrenoreceptor gene in obese women.
A population of 531 obese women was analyzed in cross-sectional survey. A bioimpedance, blood pressure, a serial assessment of nutritional intake with 3 days written food records and biochemical analysis were performed. Genotype of beta 3 adrenoreceptor gene polymorphism (Trp64Arg) was studied.
Prevalence of metabolic syndrome (MS) with ATP III definition was 47.1% (250 patients) and 52.9% patients without MS (n = 281 patients). Prevalence of beta 3 genotypes was similar in patients with metabolic syndrome (87.6% wild genotype and 12.4% mutant genotype) and without metabolic syndrome (87.9% wild genotype and 12.1% mutant genotype). Insulin and HOMA levels were higher in patients with mutant genotype than wild type, in patients with and without metabolic syndrome.
In mutant group of beta3 adrenoreceptor gene patients have higher insulin and HOMA levels than wild type group, without relation with metabolic syndrome.
据报道,β3肾上腺素能受体中的色氨酸64精氨酸(Trp64Arg)变异与体重增加和胰岛素抵抗有关。这些危险因素构成了所谓的代谢综合征。我们研究的目的是调查肥胖女性中代谢综合征与β3肾上腺素能受体基因Trp64Arg多态性之间的关系。
对531名肥胖女性进行横断面调查分析。进行生物电阻抗、血压测量,通过3天的书面饮食记录进行营养摄入的系列评估以及生化分析。研究β3肾上腺素能受体基因多态性(Trp64Arg)的基因型。
根据ATP III定义,代谢综合征(MS)的患病率为47.1%(250例患者),无MS的患者为52.9%(n = 281例患者)。代谢综合征患者(87.6%野生基因型和12.4%突变基因型)和无代谢综合征患者(87.9%野生基因型和12.1%突变基因型)中β3基因型的患病率相似。在有和无代谢综合征的患者中,突变基因型患者的胰岛素和HOMA水平均高于野生型。
在β3肾上腺素能受体基因的突变组中,患者的胰岛素和HOMA水平高于野生型组,与代谢综合征无关。